Walleye Capital’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
SR
Walleye Capital's OCUL Position: Q3 2026 in Review
Walleye Capital reduced its Ocular Therapeutix (OCUL) stake by 93% in Q3 2026, selling an estimated $1.84M and leaving 13,349 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #5180.
Walleye Capital first reported a position in OCUL in Q1 2020 and has held it in 13 quarters since. The position peaked at $6.28M in Q1 2026. 262 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- Walleye Capital held 13,349 shares of Ocular Therapeutix worth $102K as of Q3 2026.
- Walleye Capital sold 188,433 Ocular Therapeutix shares in Q3 2026, an estimated $1.84M.
- Ocular Therapeutix made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5180 holding.
- Walleye Capital first reported a position in Ocular Therapeutix in Q1 2020 and has held it in 13 quarters since.
- Walleye Capital's Ocular Therapeutix position peaked at $6.28M in Q1 2026.
- 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.